Cargando…
Incremental Hemodialysis: What We Know so Far
Traditionally, patients that develop progressive chronic kidney disease in need of kidney replacement therapy are prescribed thrice weekly in-center hemodialysis sessions at the beginning of therapy. This empiric prescription is based on historic trials that were comprised of mostly prevalent patien...
Autores principales: | Soi, Vivek, Faber, Mark D, Paul, Ritika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065374/ https://www.ncbi.nlm.nih.gov/pubmed/35520631 http://dx.doi.org/10.2147/IJNRD.S286947 |
Ejemplares similares
-
Anabaenopeptins: What We Know So Far
por: Monteiro, Patrick Romano, et al.
Publicado: (2021) -
What we know so far
Publicado: (2021) -
Amyloidogenesis: What Do We Know So Far?
por: Alraawi, Zeina, et al.
Publicado: (2022) -
Autoimmune pancreatitis: What we know so far
por: Masood, Muaaz
Publicado: (2021) -
Smoking and COVID-19: What we know so far
por: Shastri, Madhur D., et al.
Publicado: (2021)